Veeva Commercial Cloud Selected by Idorsia to Accelerate Digital Engagement Globally

Veeva provides leading-edge biopharmaceutical company commercial foundation to launch innovative new medicines

Veeva Systems announced that Idorsia Pharmaceuticals Ltd has selected Veeva Commercial Cloud to enable its digital field force in the U.S., Japan, and countries across Europe. Idorsia is at the forefront of innovative therapies and needed best-in-class cloud technology to drive its global commercial strategy. Veeva Commercial Cloud brings together multichannel engagement, data, content, and analytics to give Idorsia the foundation for digital excellence.

Recommended AI News: Couchbase Server With Couchbase Autonomous Operator Now Available On Red Hat Marketplace

“Veeva is an important partner that has helped us to rapidly scale-up, supporting our growth plans,” said Joseph Bejjani, CIO at Idorsia. “Veeva Commercial Cloud streamlines commercial processes from pre-launch planning to execution and digitally enables our field force to more effectively engage customers.”

Recommended AI News: SecureLink Announces Strategic Investment From Cove Hill Partners

Adoption of Veeva Commercial Cloud builds upon Idorsia’s success with Veeva Development Cloud in speeding end-to-end product development. Idorsia is a fast-growing biopharmaceutical company based in Switzerland with a broad portfolio of innovative drugs in its pipeline.

“Idorsia is a visionary company leading the way on digital transformation,” said Peter Gassner, founder and CEO of Veeva. “We’re thrilled to expand our partnership with Idorsia and support their digital strategy as they prepare to bring new medicines to market and help more patients.”

Recommended AI News: WISeKey And Arago Announce Unique AI Based Risk Management Approach To Build A Fully Secured Ecosystem For Managing COVID-19 Pandemic